MPS IIIA
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Follow-up Study of AAV-Mediated Gene Transfer (UX111; Previously Known as ABO-102) for MPS Type IIIA (NCT04360265) | Ultragenyx Pharmaceutical Inc | 2020-09-28 |
| Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease (NCT04088734) | Ultragenyx Pharmaceutical Inc | 2019-09-18 |
| Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH (NCT02716246) | Ultragenyx Pharmaceutical Inc | 2016-04-25 |
Track MPS IIIA automatically
Every clearance here is in the API, with alerts when new ones post.